Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Bigger

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Regulatory Toxicology and Pharmacology : RTP|September 29, 2009
Current regulatory perspectives on genotoxicity testing for botanical drug product development in the U.S.AKuei-Meng Wu, Jinhui Dou, Hanan Ghantous, et al.
Mutation Research|December 5, 2006
Strategy for genotoxicity testing--metabolic considerationsWarren W Ku, Anita Bigger, Giovanni Brambilla, et al.
American Journal of Therapeutics|May 11, 2004
Regulatory toxicology perspectives on the development of botanical drug products in the United StatesKuei-Meng Wu, James Farrelly, Debra Birnkrant, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Regulatory Toxicology and Pharmacology : RTP|September 29, 2009
Current regulatory perspectives on genotoxicity testing for botanical drug product development in the U.S.AKuei-Meng Wu, Jinhui Dou, Hanan Ghantous, et al.
Mutation Research|December 5, 2006
Strategy for genotoxicity testing--metabolic considerationsWarren W Ku, Anita Bigger, Giovanni Brambilla, et al.
American Journal of Therapeutics|May 11, 2004
Regulatory toxicology perspectives on the development of botanical drug products in the United StatesKuei-Meng Wu, James Farrelly, Debra Birnkrant, et al.
Pageof 1